| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/03/2006 | US20060172343 Isolated using polymerase chain reaction using primers ; gene therapy; wound heaaling agents |
| 08/03/2006 | US20060172327 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 08/03/2006 | US20060172322 Mutations in the C7orf11 (TTDN1) gene causative of non-photosensitive trichothiodystrophy |
| 08/03/2006 | US20060172321 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 08/03/2006 | US20060172311 Markers for cardiac disease, sensitive and accurate; expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue; measurement of these markers, samples provides information that can correlate with diagnosis of cardiac disease |
| 08/03/2006 | US20060172308 Labeling reagents and labeled targets comprising nonmetallic porphyrins |
| 08/03/2006 | US20060172300 Method for identifying bhs-specific proteins and fragments thereof |
| 08/03/2006 | US20060172298 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/03/2006 | US20060172297 Enhancers specific to motor nerve cells/sensory nerve cells |
| 08/03/2006 | US20060172296 Novel gene associated with rheumatoid arthritis |
| 08/03/2006 | US20060172290 Nucleic acids coding for a protein interacting with a porin channel |
| 08/03/2006 | US20060172287 Murine calicivirus |
| 08/03/2006 | US20060172281 method with which endotoxins can be removed from aqueous solutions using bacteriophage tail proteins |
| 08/03/2006 | US20060172011 Medical treatment |
| 08/03/2006 | US20060172008 formed from plasma proteins comprising fibrinogen, thrombin and Factor XIII, the matrix having less than 10% residual moisture and being devoid of external anti-fibrinolytic agents; sponges; useful as cell-bearing implants |
| 08/03/2006 | US20060172001 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 08/03/2006 | US20060171967 Means and methods for diagnosing a treponema infection |
| 08/03/2006 | US20060171965 Fusion proteins of mycobacterium tuberculosis |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171962 SARS vaccine |
| 08/03/2006 | US20060171961 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 08/03/2006 | US20060171959 Virulence genes, proteins, and their use |
| 08/03/2006 | US20060171957 Polypeptide-vaccines for broad protetion against hypervirulent meningococcal lineages |
| 08/03/2006 | US20060171955 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | US20060171953 Tumour-specific animal proteins |
| 08/03/2006 | US20060171937 Method of treating chronic cardiac disease |
| 08/03/2006 | US20060171931 Modulators of Wnt signalling pathways and screening methods to identify them; muscular dystrophy; inhibitors of soluble Frizzled-related proteins |
| 08/03/2006 | US20060171922 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 08/03/2006 | US20060171921 Glycosylated interferon |
| 08/03/2006 | US20060171920 derivatization of the drug with 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS) removable under mild basic conditions by attaching a protein or polymer carrier to derivatized drug molecule,such carrier serving for delivery of the drug |
| 08/03/2006 | US20060171919 Targeted polypeptides |
| 08/03/2006 | US20060171918 Apoptosis inducing molecule I |
| 08/03/2006 | DE19632862B4 Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines |
| 08/03/2006 | DE102005002978A1 Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 08/03/2006 | DE102005002969A1 Verfahren zum Nachweis und zur Entfernung von Endotoxin A method for the detection and removal of endotoxin |
| 08/03/2006 | CA2596537A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | CA2595935A1 Therapeutic peptides derived from urokinase plasminogen activator receptor |
| 08/03/2006 | CA2595892A1 Ephb receptor-binding peptides |
| 08/03/2006 | CA2595778A1 Anti-muc1 .alpha..beta. antibodies |
| 08/03/2006 | CA2595727A1 Means and methods for breaking noncovalent binding interactions between molecules |
| 08/03/2006 | CA2595726A1 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| 08/03/2006 | CA2595695A1 Conjugates of biologically active proteins having a modified in vivo half-life |
| 08/03/2006 | CA2595679A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 08/03/2006 | CA2595676A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | CA2594502A1 Homogeneous preparations of il-31 |
| 08/03/2006 | CA2593801A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/03/2006 | CA2593351A1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/02/2006 | EP1686379A1 Fluorescence indicator utilizing fret |
| 08/02/2006 | EP1686187A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 08/02/2006 | EP1686186A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 08/02/2006 | EP1686185A1 Process for producing lactic acid bacerium culture containing bacteriocin and method of storing food using the same |
| 08/02/2006 | EP1686181A2 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 08/02/2006 | EP1686180A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 08/02/2006 | EP1686175A2 Proteins and nucleic acids encoding same |
| 08/02/2006 | EP1686174A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/02/2006 | EP1686172A2 Myocardial grafts and cellular compositions useful for same |
| 08/02/2006 | EP1686136A1 Novel glycoprotein and medicinal composition containing the same |
| 08/02/2006 | EP1686135A1 G protein-coupled receptors |
| 08/02/2006 | EP1686134A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/02/2006 | EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685405A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 08/02/2006 | EP1685402A2 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin |
| 08/02/2006 | EP1685256A1 Method for flocculation of a fermentation broth comprising a fungus |
| 08/02/2006 | EP1685251A2 Nucleic acid constructs |
| 08/02/2006 | EP1685250A1 Proteins involved in signal transduction |
| 08/02/2006 | EP1685245A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 08/02/2006 | EP1685238A2 Hcv replicons containing ns5b from genotype 2b |
| 08/02/2006 | EP1685160A1 Dry recombinant human alpha 1-antitrypsin formulation |
| 08/02/2006 | EP1685159A2 Tim-3 polypeptides |
| 08/02/2006 | EP1685158A1 Gnal splice variant and uses thereof |
| 08/02/2006 | EP1685157A2 Novel therapeutic targets in cancer |
| 08/02/2006 | EP1685156A2 Novel agents for the prevention of leishmaniosis |
| 08/02/2006 | EP1685155A2 "seedy1" nuceic acids for making plants having changed growth characteristics |
| 08/02/2006 | EP1685154A1 Purification method for a recombinant glucose binding protein |
| 08/02/2006 | EP1685153A1 Targeting compositions and preparation thereof |
| 08/02/2006 | EP1685151A2 Neural regeneration peptides and methods for their use in treatment of brain damage |
| 08/02/2006 | EP1684795A1 Methods and agents for the treatment of cancer |
| 08/02/2006 | EP1684793A1 Soluble pharmaceutical compositions for parenteral administration comprising a glp-1 peptide and a insulin peptide of short time action for treatment of diabetes and bulimia |
| 08/02/2006 | EP1684789A2 Mammalian t1r3 sweet taste receptors |
| 08/02/2006 | EP1684788A2 Peptide increasing fusiogenic capacity of a gamete |
| 08/02/2006 | EP1684719A2 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 08/02/2006 | EP1684692A2 Pigment epithelium-derived factor, novel biological activity and methods of use |
| 08/02/2006 | EP1578762A4 A novel pth responsive gene |
| 08/02/2006 | EP1569959A4 Bcl-w structure and uses therefor |
| 08/02/2006 | EP1543026B1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 08/02/2006 | EP1511761B1 Process for production of cyclic peptides |
| 08/02/2006 | EP1506227B1 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family |
| 08/02/2006 | EP1504031B1 Method for albumin purification |
| 08/02/2006 | EP1490680A4 Identifying peptide modifications |
| 08/02/2006 | EP1440149B1 Use of an infectious and attenuated type ii bovine viral diarrhea virus clone to prevent foetal infection by type i bvdv |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1417333A4 Pna probes, probe sets, methods and kits pertaining to the detection of candida |
| 08/02/2006 | EP1397154B1 Abin-mediated hepatitis protection |
| 08/02/2006 | EP1381675B1 Method for replicating the hepatitis c virus |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1143800B1 Biological control of nematodes |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |